U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CILGAVIMAB
1KUR4BN70F
Investigational
General
Names
9
Identifiers
8
Subunits
4
Related Substances
1
CILGAVIMAB
1KUR4BN70F
Investigational
General
Approval Year
Unknown
139,594
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CILGAVIMAB
Official Name
English
COV2-2130
Code
English
AZD1061
Code
English
CILGAVIMAB [JAN]
Common Name
English
IMMUNOGLOBULIN G1 (248-THREONINE,249-METHIONINE,316-TYROSINE,318-THREONINE,320-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL AZD1061 .GAMMA.1-CHAIN), DISULFIDE WITH HUM
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
2587306
PRIMARY
NCI_THESAURUS
C177058
PRIMARY
CAS
2420563-99-9
PRIMARY
SMS_ID
300000026511
PRIMARY
INN
11777
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
1KUR4BN70F
CILGAVIMAB